Roche cancer immunotherapy Tecentriq wins EU approvalReutersZURICH (Reuters) – Roche immunotherapy Tecentriq has won European Union approval for treating advanced lung and bladder cancer, the Swiss drugmaker said. The European Commission approved Tecen… Continue reading
|
Backed by Yale Cancer Center Research, FDA Approves New Immunotherapy Drug for Stomach Cancer
Newswise (press release) A drug whose clinical testing was led by Charles S. Fuchs, MD, MPH, director of Yale Cancer Center, has become the first immunotherapy treatment for advanced stomach cancer. The drug, pembrolizumab (Keytruda®), was approved by the U.S. Food and … |
Cancer Research UK (blog) |
News digest – lung cancer drug, vaping, HPV, and… CRISPR genome editing?
Cancer Research UK (blog) We reported on a promising immunotherapy drug, nivolumab (Opdivo), being made available to certain lung cancer patients in England. NICE, who decides on availability of NHS treatments, said it could be given to patients with advanced non-small cell … |
Barron’s |
Gene Therapy Is Nearing a Major Breakthrough
Barron’s After decades of research and development, gene therapy is rapidly emerging as one of the most exciting areas in biotechnology—and generating new hope for patients with certain rare and often deadly inherited diseases. Replacement gene therapy that … |
MLB.com |
Britton undergoes stem–cell injection in left knee
MLB.com BALTIMORE — Orioles closer Zach Britton had a stem–cell injection in his left knee on Friday, a move that will likely end the left-hander’s 2017 season. Orioles manager Buck Showalter wouldn’t officially say whether Britton will get another outing … |